New ‘Fast-Acting’ Migraine Drug Approved By FDA

Topline The Food and Drug Administration on Friday approved a new nasal spray drug giant Pfizer says could offer “fast-acting relief” from migraines, launching a new form of medicine onto the market a...

Pfizer deal will help expand reach of migraine pill

Pfizer‘s purchase of migraine medication maker Biohaven Pharmaceutical represents a commitment to expand the reach of its calcitonin gene-related peptide (CGRP) franchise, CEO Vlad Coric told CN...

AXSM Stock Reverses Its Good Fortune On A Roadblock For Its Migraine Drug

Axsome Therapeutics (AXSM) says it expects the Food and Drug Administration to reject its migraine treatment, leading AXSM stock to crumble on Monday. X In a filing with the Securities and Exchange Co...